Karolinska Development AB (publ) (STO: KDEV)

Sweden flag Sweden · Delayed Price · Currency is SEK
1.324
-0.046 (-3.36%)
Aug 30, 2024, 5:29 PM CET
-20.72%
Market Cap 357.26M
Revenue (ttm) 1.90M
Net Income (ttm) -5.65M
Shares Out 269.83M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 970,165
Open 1.300
Previous Close 1.370
Day's Range 1.280 - 1.374
52-Week Range 1.280 - 1.948
Beta 0.25
Analysts n/a
Price Target n/a
Earnings Date Nov 15, 2024

About Karolinska Development AB

Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio com... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2003
Employees 8
Stock Exchange Nasdaq Stockholm
Ticker Symbol KDEV
Full Company Profile

Financial Performance

News

There is no news available yet.